Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-01-10 @ 11:16 PM
Study NCT ID:
NCT00624351
Status:
COMPLETED
Last Update Posted:
2011-09-12
First Post:
2008-02-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease
Sponsor:
UCB Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-15
First Submit QC Date:
None
Study First Post Date:
2008-02-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-11-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-09-02
Last Update Post Date:
2011-09-12
Last Update Post Date Type:
ESTIMATED